J van der Woude

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Geert D’Haens, Filip Baert, Gert Van Assche et al. · The Lancet · 2008 · 1.2K citations

Autoimmune Disease, Immunosuppressive Therapy, Immunology +5

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

Matthieu Allez, Konstantinos Κarmiris, Édouard Louis et al. · Journal of Crohn s and Colitis · 2010 · 336 citations · Full text

Inflammation, Rheumatology, Chronic Inflammatory Diseases +15

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 173 citations

Terminal Ileitis, Medicine, C Trial +5

The impact of biologics on health-related quality of life in patients with inflammatory bowel disease

Lauran Vogelaar, J van der Woude, Adriaan van’t Spijker · Clinical and Experimental Gastroenterology · 2009 · 85 citations · Full text

Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study

Tessa Straatmijer, Vince Biemans, Marijn C. Visschedijk et al. · Clinical Gastroenterology and Hepatology · 2022 · 47 citations · Full text